2 Major Themes from Public Healthcare Firms trailing COVID-19 – Part 2: Looking Forward

Contributors: Savanna Dinkel, Blake Madden and Chris Madden Providers: Continued Shift to the Outpatient Setting With the roll-out of the vaccine and the lifting of COVID-19 restrictions, providers are able to look further forward towards their operations in a post-pandemic world. During Q4 2020 earnings calls, the latest occurring on March 8, 2021 (RadNet), management… Read More

Key Takeaways from the Medscape Physician Compensation Report 2021

Written by Caroline Dean and Bartt B. Warner, CVA As the COVID-19 pandemic presented unique challenges for healthcare providers and beyond, physician compensation has mostly trended back toward pre-COVID levels per the Medscape Physician Compensation Report 2021 (“Medscape Report”). According to the Medscape Report, which included information from 17,903 physicians in over 29 specialties, average… Read More

2021 Diagnostic Imaging Rate Changes: Impact & Outlook

Written by Greg Henderson & Samuel Betsill Diagnostic imaging in the United States is estimated to generate over $100 billion annually, with outpatient, non-hospital-based imaging accounting for approximately 40% of the total market. Since Congress passed the Deficit Reduction Act of 2005, significant reimbursement rate cuts have been made to the diagnostic imaging business. Since… Read More

2 Major Themes from Public Healthcare Firms Trailing COVID-19 – Part 1: COVID’s Trailing Effects

Contributors: Madi Whyde, Alex Malin, Spencer Coronado, Keith Ponsler As the healthcare sector begins to recover from the coronavirus (“COVID-19”) pandemic, insights and experiences from payors and providers paint an optimistic picture for 2021. In this two-part series, VMG has summarized key observations regarding the following two major themes from public healthcare firms: Part 1:… Read More

Quality Metrics & FMV: By Specialty Considerations

Written by Kyle Spears and Jen Johnson, CFA The value-based care reimbursement environment has emphasized the evaluation of quality by measuring performance with metrics. As a result, hospital executives, management, providers, and legal counsel all share a fundamental question: what are the guidelines to selecting metrics that properly measure the quality of care and are… Read More

Oncology Reimbursement Environment – Recent Changes, Impact and Outlook

reimbursement oncology

Written By: David LaMonte, Ayla Anstice, William Teague & Anthony Metke Understanding the business of cancer treatment in the United States today is predicated on keeping pace with evolving payment models and reimbursement levels promulgated from the Center for Medicare and Medicaid Services (“CMS”) and other government organizations. VMG has identified four areas where CMS… Read More

ASCs in 2020: A Year in Review

ASCs 2020

Written by Jack Hawkins & Colin Park, CPA/ABV, ASA 2020 was a unique year for the healthcare industry as it experienced a once in a lifetime event. While the healthcare market as a whole was tremendously impacted by the coronavirus (“COVID-19”) pandemic, the Ambulatory Surgery Center (“ASC”) sub-industry was acutely impacted due to interruptions in… Read More

3 Major Themes from Public Healthcare Firms during COVID-19 – Part 3: Mergers & Acquisitions

Contributors: Colin McDermott, Anthony Metke, Spencer Coronado As the healthcare sector continues to operate affected by the coronavirus (“COVID-19”) pandemic, insights and experiences from the provider sector are particularly interesting. In this three-part series, VMG Health has summarized key observations regarding the following three major themes from public healthcare firms: Part 1: COVID-19’s impact on… Read More

3 Major Themes from Public Healthcare Firms during the Third Quarter of 2020 – Part 2: Expense Management and Cost Savings

Contributors: Madison Whyde, Alex Malin, Chris Madden Among the companies covered for Q3 2020, there was a continued emphasis on expense management and cost savings strategies. As mentioned in Part 1, COVID-19 restrictions began to ease up in many markets with patient volume reapproaching normalized levels. While many companies are still experiencing increased costs related… Read More

Spotlight on Life Sciences – Healthcare Real Estate

life sciences real estate

Written by Grace McWatters, Victor McConnell, MAI, ASA, CRE, Larry Snyder, MAI Largely driven by growth in the biotechnology research and development segment, real estate associated with the life sciences, which utilizes a combination of office, flex, and lab space, has emerged as a highly favored asset. Accounting for approximately 100 million square feet of… Read More